National Cancer Control Programme
Please click on the links below to access NCCP guidance, documents and resources
NCCP Systemic Anti-Cancer Model of Care
The NCCP Guidance on the use of Biosimilars in Cancer Treatment has been retired ( May 2024). Please see link to HSE Guidance for Biological and Biosimilar Medicines use in Acute Hospitals here
NCCP Guidance on the Provision of Parenteral SACT and Supportive Care in the Community
NCCP Guidance on bevacizumab Rapid Infusion Rate
NCCP Guidance on riTUXImab Rapid Infusion Rate
NCCP Oncology Medication Safety Review
Oral Anti-Cancer Medicines Model of Care (Rec 80)
Minimum Personnel for Day Wards (Rec 16)
Consent Form for SACT (National Template) (Rec 37)
Guidance on the Built Environment of a Haematology/ Oncology Day Ward (Rec 9)
NCCP Guidance on Intrathecal Chemotherapy
NCCP Guidance on Neurotoxins (including Vinca Alkaloids)
NCCP Guidance on Dose Banding for SACT
NCCP Guidance: Making Best Use of SACT Aseptic Compounding Capacity
NCCP Guidance Document for Off Site Transportation of Products from Hospital Pharmacy
NCCP Guidance: Pharmacy Benchtop preparation of monoclonal antibodies (mAbs) used in the treatment of cancer
NCCP Guidance: Patient selection for the use of immunoglobulin replacement therapy in cancer patients with secondary immunodeficiency
NCCP-Guidance-on-Management--challenges-in-medical-oncology--haematology-day-units.pdf (size 679.1 KB)
NCCP Service Specification for Haemato-oncology Services
NCCP Guidance: Prevention and Management of Extravasation of Systemic Anti-Cancer Therapy (SACT)
NCCP Position Paper on the use of Tall Man Lettering
Template SOP for SACT Transportation
NCCP Olaparib Tablets Communication to Pharmacists
Testing to inform PARP inhibitor cancer treatment
NCCP Quality Assurance Resources for Hospital Pharmacy Cancer Services
NCCP Extravasation Classification of Systemic Anti-Cancer Therapy
NCCP Capacity Planning for Parenteral SACT (Pharmacy)
NCCP Hospital Pharmacy Cancer Services Workforce Planning Framework
NCCP SACT regimens
List of approved drugs for reimbursement
NCCP Guidance on the Retention and Disposal of SACT Prescriptions and Compounding Worksheets
Education and Training
NCCP Evidence Reviews
Pharmacy Cancer Clinical Trial Feasibility Checklist
Pharmacy Cancer Clinical Trial Initiation Checklist
Patient Assessment Forms
